03/26/2024 4:01 PM | Annexon (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/26/2024 4:05 PM | Annexon (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/26/2024 3:05 PM | Annexon (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/26/2024 3:10 PM | Annexon (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/20/2024 2:12 PM | Annexon (Subject) Overdorf Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 2:12 PM | Annexon (Subject) Lew Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 2:15 PM | Annexon (Subject) Yednock Ted (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
02/14/2024 7:46 PM | Annexon (Subject) Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024 6:56 PM | Annexon (Issuer) Love Douglas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 6:59 PM | Annexon (Issuer) Overdorf Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 6:52 PM | Annexon (Issuer) Yednock Ted (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 6:54 PM | Annexon (Issuer) Lew Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 2:45 PM | Annexon (Subject) Fairmount Funds Management LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 11:43 AM | Annexon (Subject) EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 9:26 AM | Annexon (Subject) BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G/A | |
02/13/2024 6:23 PM | Annexon (Subject) Logos Global Management LP (Filed by)
| Form SC 13G/A | |
02/13/2024 5:57 PM | Annexon (Subject) Bain Capital Life Sciences Fund, L.P. (Filed by)
| Form SC 13G/A | |
02/12/2024 2:39 PM | Annexon (Subject) Yednock Ted (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 2:40 PM | Annexon (Subject) Lew Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 2:41 PM | Annexon (Subject) Love Douglas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 2:45 PM | Annexon (Subject) Overdorf Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024 6:02 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Annexon (Subject)
| Form SC 13G/A | |
01/23/2024 3:57 PM | Annexon (Issuer) Lew Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 3:58 PM | Annexon (Issuer) Overdorf Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 7:53 AM | Annexon (Subject) FMR LLC (Filed by)
| Form SC 13G | |
12/29/2023 3:12 PM | Annexon (Issuer) Yednock Ted (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 3:30 PM | Annexon (Issuer) Annexon (Issuer) Satter Muneer A (Reporting) Satter Muneer A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 3:50 PM | Annexon (Subject) Yednock Ted (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 4:28 PM | Annexon (Filer)
| Form 8-K/A | |
12/20/2023 4:17 PM | Annexon (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2023 4:24 PM | Annexon (Subject)
| Form FWP | |
10/24/2023 3:30 PM | Annexon (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/11/2023 3:44 PM | Annexon (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2023 7:36 AM | Annexon (Subject) FEDERATED HERMES, INC. (Filed by) FEDERATED HERMES, INC. (Filed by)
| Form SC 13G/A | |
07/13/2023 2:37 PM | Annexon (Subject) Lew Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023 2:26 PM | Annexon (Subject) Overdorf Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023 2:31 PM | Annexon (Subject) Yednock Ted (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/22/2023 12:25 PM | Annexon (Subject) Logos Global Management LP (Filed by)
| Form SC 13G | |
06/12/2023 4:52 PM | Annexon (Issuer) Satter Muneer A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 3:45 PM | Annexon (Issuer) Waddill William D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 3:48 PM | Annexon (Issuer) Cockroft Bettina M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Urgent: Protect Your Investments from a Chinese Invasion (Ad) An alarming new reality is unfolding across America.
The United States is bracing for the unthinkable - a potential Chinese invasion. Click here to get my exclusive report NOW >>> |
06/12/2023 3:49 PM | Annexon (Issuer) Choi Jung (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 3:50 PM | Annexon (Issuer) WIGGANS THOMAS G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2023 8:54 PM | Annexon (Issuer) Bain Capital Life Sciences Fund, L.P. (Reporting) Bain Capital Life Sciences Investors, LLC (Reporting) Bain Capital Life Sciences Partners, LP (Reporting) BCIP Life Sciences Associates, LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2023 8:55 PM | Annexon (Issuer) Bain Capital Life Sciences Fund, L.P. (Reporting) Bain Capital Life Sciences Investors, LLC (Reporting) Bain Capital Life Sciences Partners, LP (Reporting) BCIP Life Sciences Associates, LP (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/25/2023 5:08 AM | Annexon (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |